Boult Wade Tennant
Bulletins » The UPCs widening jurisdiction over European patents

A recent decision of the Paris Local Division of the UPC has confirmed that where a defendant is domiciled in the EU the UPC is competent to decide on infringement for all parts of a European patent. This includes non-UPC states such as Spain and non-EU states such as Switzerland and the UK. In addition, while the Court confirmed that it could not legally revoke a European patent in a ‘third-state’ – such as the UK – it held that it can decide on the validity of the European patent in ‘third-states’ with binding effect for the parties involved in the UPC action.

The case of Mul-T-Lock France & Mul-T-Lock Suisse vs. IMC Creations (UPC_CFI_702/2024) follows swiftly on from the CJEU decision of BSH Hausgeräte v Electrolux that decided, based on the Brussels Regulation, that where a defendant is domiciled in the EU the UPC has jurisdiction to hear actions for infringement in all countries covered by the European patent irrespective of whether the states are party to the UPC or in the EU.

In Mul-T-Lock France & Mul-T-Lock Suisse vs. IMC Creations the Paris Division not only confirmed the approach of BSH Hausgeräte v Electrolux but appears to have gone further in two important respects:

  • First, the Court considered themselves to be competent to decide on infringement in Switzerland by a Swiss group company Mul-T-Lock Suisse despite this defendant not being domiciled in an EU state. The Court’s brief reasoning argued that the Lugano Convention (of which Switzerland is a signatory) provided a basis equivalent to that of the Brussels Regulation and the presence of at least one EU-based defendant (here Mul-T-Lock France) was sufficient.
  • Secondly, the Court held that in respect of ‘third-states’ such as the UK – which are not part of the EU or party to the Brussels Regulation or Lugano Convention – the Court can give binding decisions not only on infringement but also on validity that are effective inter partes, that is binding on the parties litigating the action before the UPC.

So, the UPCs jurisdiction continues to expand, with the aim it appears of becoming the de facto forum for litigating infringement and validity of European patents for all states – at least where at least one defendant is domiciled in the EU. We will need to wait and see whether future decisions will look to expand the UPCs jurisdiction for non-EU domiciled defendants or to ‘third-states’ not covered by a European patent. It will also be of interest to see what view courts in ‘third-states’ such as the UK take to inter partes validity decisions issued by the UPC. Will, say, the UK courts consider themselves estopped from hearing an action between the same parties, and how much weight will be given by the UK courts to a prior finding of invalidity in a case relating to a different alleged infringer?

Read our latest UPC insights.

Relevant sectors
Aerospace
  • Commercial aviation
  • Defence and security
  • Space and satellites
  • Unmanned aerial vehicles
Artificial Intelligence and Machine Learning
Automotive
  • Autonomous vehicles
  • Electric vehicles
  • Engines
Biotechnology
  • Antibody engineering
  • Antibody manufacture and formulation
  • Bioinformatics
  • Biosimilars
  • Drug delivery
  • Gene editing (e.g. CRISPR)
  • Genomic and molecular tools and methods
  • GM crops
  • Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)
  • Next generation sequencing
  • Nucleic acid synthesis
  • Personalised medicine/disease biomarkers
  • Recombinant protein production and purification
  • Stem cell therapies
  • Supplementary protection certificates (SPCs)
  • Synthetic biology
  • Therapeutic antibodies
  • Vaccinology (e.g. viral vectors; mRNA vaccines)
  • Women’s health products
Chemicals
  • Agrochemicals
  • Catalysts
  • Dispersions and colloids
  • Lubricants
  • Polymers and plastics
Communications and Networks
  • Cloud computing
  • Internet of things (IOT)
  • Oceanography, marine
  • Wired and wireless networks
Computing and Software
  • Artificial intelligence and machine learning
  • Bioinformatics
  • Blockchain and distributed ledgers
  • Communications and networks
  • Computer games
  • Data and software security, cryptography and digital rights management (DRM)
  • Data management and storage, databases and data compression
  • Digital assistants, virtual assistants and software agents
  • Fintech and adtech
  • Machine vision
  • Metaverse, virtual reality (VR) and augmented reality (AR)
  • Motor capture
  • Multimedia, audio/video processing and animation
  • Natural language processing
  • Quantum computing
  • Robotic process automation
  • Search engines
  • Signal processing
  • Software applications and systems, mobile applications, user interfaces
Consumer Goods and Retail
  • Anti-counterfeit devices
  • Beauty
  • Fashion
  • Health, fitness and sport
  • Household goods
  • Luxury goods
  • Moda
  • Retail
Electronics and Electrical Devices
  • Computer and IT architecture and system design
  • Medical devices
  • Optics
  • Restaurants and bars
  • Robotics
  • Scientific instruments
  • Semiconductor devices
  • Testing systems, control systems, signal processing
  • Travel and leisure
  • Wearable tech and human interfaces
Energy and Green Technologies
  • Biofuels
  • Clean air
  • Fuel cells and battery technology
  • Renewables and recycling
  • Solar power
  • Water, oil and gas, nuclear, fusion, fission
  • Wind turbines
Food and Beverage
  • Beverages
  • Nutrition
  • Retail
Industrial Manufacturing and Processing
  • Packaging
  • Polymers and plastics
  • Printing tech
  • Additive manufacturing
  • Coatings
  • Construction
Materials
  • Advanced materials
  • Composite materials
  • Metallurgy and alloys
  • Nanotechnology
Medical Devices and Diagnostics
  • Artificial intelligence
  • Devices
  • Diagnostic instruments
  • Digital health
  • Drug delivery
  • Immuno-oncology
  • In vitro diagnostics
  • Medtech
Pharmaceuticals
  • Diagnostics
  • Drug delivery
  • Generic market entry
  • Medicinal chemistry
  • Methods of production and synthesis
  • Personalised medicine/disease biomarkers
  • Pharmaceutical formulations
  • Pharmaceuticalsceutical formulations
  • Polymorphs
  • Small molecule pharmaceuticals
  • Supplementary protection certificates (SPCs)
Trade Marks
  • Consumer goods
  • Cosmetics and perfumery
  • Financial services
  • Mechanical engineering
  • Mechanical products
  • Services
  • Telecommunications
Relevant sectors